Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
A selection of articles from the 2011 issue of Turning Point.
To see the entire publication, please download the PDF version. If you'd like to receive a print version of Turning Point in the mail, please complete this form.
How the Susan F. Smith Center for Women's Cancers is building on a legacy of successes.
Dana-Farber's experts answer questions about breast and ovarian cancer.
HER2, a growth factor receptor model, is active in a very small number of ovarian cancers, but its genetic cousin, HER3, has been estimated to be abnormal in 25 to 30 percent of ovarian tumors.
Researchers have begun probing the relatively unknown cellular territory of cervical cancer, hunting for new opportunities to block the mutated gene pathways driving the cancer.
The promise and potential limitations of a new class of cancer drugs.
Turning Point is published for supporters of Dana-Farber's Susan F. Smith Center for Women's Cancers. To learn more about the Susan F. Smith Center and its offerings, call Administrative Director Candace S. Lowe, ScD, at 617-632-2675.
Comments, suggestions, and requests to be added to or deleted from the mailing list may be sent to:
Turning PointDana-Farber Cancer InstituteDepartment of Communications450 Brookline Ave.Boston, MA 02115Phone: 617-632-4090Email: TurningPoint@dfci.harvard.edu